Literature DB >> 18263602

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Alan R Kristal1, Kathryn B Arnold, Jeannette M Schenk, Marian L Neuhouser, Phyllis Goodman, David F Penson, Ian M Thompson.   

Abstract

This study examined dietary risk factors for incident benign prostatic hyperplasia (BPH) in 4,770 Prostate Cancer Prevention Trial (1994-2003) placebo-arm participants who were free of BPH at baseline. BPH was assessed over 7 years and was defined as medical or surgical treatment or repeated elevation (>14) on the International Prostate Symptom Score questionnaire. Diet, alcohol, and supplement use were assessed by use of a food frequency questionnaire. There were 876 incident BPH cases (33.6/1,000 person-years). The hazard ratios for the contrasts of the highest to lowest quintiles increased 31% for total fat and 27% for polyunsaturated fat and decreased 15% for protein (all p(trend) < 0.05). The risk was significantly lower in high consumers of alcoholic beverages (0 vs. > or =2/day: hazard ratio (HR) = 0.67) and vegetables (<1 vs. > or =4/day: HR = 0.68) and higher in daily (vs. <1/week) consumers of red meat (HR = 1.38). There were no associations of supplemental antioxidants with risk, and there was weak evidence for associations of lycopene, zinc, and supplemental vitamin D with reduced risk. A diet low in fat and red meat and high in protein and vegetables, as well as regular alcohol consumption, may reduce the risk of symptomatic BPH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263602     DOI: 10.1093/aje/kwm389

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  65 in total

Review 1.  Lifestyle and lower urinary tract symptoms: what is the correlation in men?

Authors:  Pao-Hwa Lin; Stephen J Freedland
Journal:  Curr Opin Urol       Date:  2015-01       Impact factor: 2.309

Review 2.  An update on the health effects of tomato lycopene.

Authors:  Erica N Story; Rachel E Kopec; Steven J Schwartz; G Keith Harris
Journal:  Annu Rev Food Sci Technol       Date:  2010

3.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Marian L Neuhouser; Cathee Till; Alan Kristal; Phyllis Goodman; Ashraful Hoque; Elizabeth A Platz; Ann W Hsing; Demetrius Albanes; Howard L Parnes; Michael Pollak
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

4.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

5.  Role of complimentary therapy for male LUTS.

Authors:  Philippa J Cheetham
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 6.  Dietary patterns, supplement use, and the risk of benign prostatic hyperplasia.

Authors:  Kenneth S Poon; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

Review 7.  [Primary and secondary prevention of benign prostatic hyperplasia: current knowledge and implications for clinical management].

Authors:  M Oelke; S Madersbacher
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 8.  The effect of diet on BPH, LUTS and ED.

Authors:  Mahmoud ElJalby; Dominique Thomas; Dean Elterman; Bilal Chughtai
Journal:  World J Urol       Date:  2018-11-23       Impact factor: 4.226

Review 9.  Increased dietary and circulating lycopene are associated with reduced prostate cancer risk: a systematic review and meta-analysis.

Authors:  J L Rowles; K M Ranard; J W Smith; R An; J W Erdman
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-04-25       Impact factor: 5.554

10.  Evaluation of web-based, self-administered, graphical food frequency questionnaire.

Authors:  Alan R Kristal; Ann S Kolar; James L Fisher; Jesse J Plascak; Phyllis J Stumbo; Rick Weiss; Electra D Paskett
Journal:  J Acad Nutr Diet       Date:  2014-01-24       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.